Nutrition, Microbiota and Noncommunicable Diseases

Health is defined as “the state of the organism when it functions optimally without evidence of disease”. Surprisingly, the words “microbes” or “microorganism” are missing in this definition. The regulation of gut microbiota is mediated by an enormous quantity of aspects, such as microbiological fac...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (416 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05541nam-a2201525z--4500
001 993545522704498
005 20231214133541.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000042990 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68960 
035 |a (EXLCZ)995400000000042990 
041 0 |a eng 
100 1 |a Plaza-Díaz, Julio  |4 edt 
245 1 0 |a Nutrition, Microbiota and Noncommunicable Diseases 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (416 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Health is defined as “the state of the organism when it functions optimally without evidence of disease”. Surprisingly, the words “microbes” or “microorganism” are missing in this definition. The regulation of gut microbiota is mediated by an enormous quantity of aspects, such as microbiological factors, host characteristics, diet patterns, and environmental variables. Some protective, structural, and metabolic functions have been reported for gut microbiota, and these functions are related to the regulation of homeostasis and host health. Host defense against pathogens is, in part, mediated through gut microbiota action and requires intimate interpretation of the current microenvironment and discrimination between commensal and occasional bacteria. The present Special Issue provides a summary of the progress on the topic of intestinal microbiota and its important role in human health in different populations. This Special Issue will be of great interest from a clinical and public health perspective. Nevertheless, more studies with more samples and comparable methods are necessary to understand the actual function of intestinal microbiota in disease development and health maintenance. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a sperm quality 
653 |a probiotics 
653 |a zebrafish 
653 |a motility 
653 |a behavior 
653 |a intestinal microbiota 
653 |a intestinal Bacteroides 
653 |a cardiorespiratory fitness 
653 |a trunk muscle training 
653 |a aerobic exercise training 
653 |a brisk walking 
653 |a nutrients 
653 |a gut microbiota 
653 |a nutrition 
653 |a habitual diets 
653 |a Western diet 
653 |a obesity 
653 |a cardiometabolic risk factors 
653 |a chronic health conditions 
653 |a gastrointestinal disorders 
653 |a prebiotics and probiotics 
653 |a metabolic syndrome 
653 |a gastrointestinal microbiome 
653 |a Lactobacillus reuteri V3401 
653 |a sugar alcohol 
653 |a prebiotic 
653 |a bowel function 
653 |a immune function 
653 |a respiratory tract infections 
653 |a otitis media 
653 |a sinusitis 
653 |a weight management 
653 |a satiety 
653 |a bone health 
653 |a AMP-activated protein kinase 
653 |a butyrate 
653 |a developmental origins of health and disease (DOHaD) 
653 |a high fat diet 
653 |a hypertension 
653 |a nutrient-sensing signals 
653 |a propionate 
653 |a short chain fatty acids 
653 |a kefir 
653 |a autism spectrum disorders 
653 |a oral microbiota 
653 |a dysbiosis 
653 |a co-occurring conditions 
653 |a allergy 
653 |a abdominal pain 
653 |a biomarker discovery 
653 |a anorexia 
653 |a food restriction 
653 |a ClpB 
653 |a microbiota 
653 |a Enterobacteriaceae 
653 |a inulin 
653 |a circadian rhythm 
653 |a feeding timing 
653 |a choline 
653 |a trimethylamine 
653 |a trimethylamine n-oxide 
653 |a 16S rRNA gene profiling 
653 |a qPCR 
653 |a linear mixed models 
653 |a soy protein 
653 |a lipid metabolism 
653 |a circadian 
653 |a chrono-nutrition 
653 |a microbiome 
653 |a pregnancy 
653 |a fetus 
653 |a placenta 
653 |a newborn 
653 |a infancy 
653 |a critical illness 
653 |a sepsis 
653 |a lipid metabolome 
653 |a amlodipine 
653 |a corticosterone 
653 |a ACTH 
653 |a gut bacteriome 
653 |a ischemia-reperfusion injury 
653 |a nutritional status 
653 |a supplemented nutrition 
653 |a partial hepatectomy 
653 |a liver transplantation 
653 |a vaginal microbiome 
653 |a bacterial communities 
653 |a vaginal dysbiosis 
653 |a bacterial vaginosis 
653 |a risk factors 
653 |a hormone replacement therapy 
653 |a cardiovascular diseases 
653 |a atherosclerosis 
653 |a prebiotics 
653 |a alanine aminotransferase 
653 |a antibiotic 
653 |a Optifast 
653 |a gut microbiome 
653 |a metronidazole 
653 |a nonnutritive sweeteners 
653 |a sweetening agents 
776 |z 3-03936-916-4 
776 |z 3-03936-917-2 
700 1 |a Plaza-Díaz, Julio  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:57:27 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338009310004498&Force_direct=true  |Z 5338009310004498  |b Available  |8 5338009310004498